Table 1.
Respondents | Sex | N | Age in years | |||
---|---|---|---|---|---|---|
15‐19 | 20‐24 | 25‐29 | 30‐39 | |||
Healthy AYA | All | 200 | 50 | 50 | 50 | 50 |
Male | 100 | 25 | 25 | 25 | 25 | |
Female | 100 | 25 | 25 | 25 | 25 | |
AYA cancer survivors | 118 | Onset | Current | Gynecologic/Breast | ||
Childhood onset | All | 76 | 7.57 ± 4.54 | 24.0 ± 5.98 | ||
Male | 32 | 7.69 ± 4.21 | 23.0 ± 5.57 | |||
Female | 44 | 7.48 ± 4.81 | 24.7 ± 6.23 | |||
AYA onset | All | 36 | 27.5 ± 5.78 | 33.2 ± 4.83* | 7/9 | |
Male | 4 | 21.3 ± 6.18 | 31.8 ± 2.63** | |||
Female | 32 | 28.3 ± 5.32 | 33.4 ± 5.03*** | 7/9 | ||
Female excluding gynecologic tumors | 26 | 29.1 ± 4.97 | 33.6 ± 5.01*** | 0/9 |
AYA, adolescent and young adult.
Age: mean ± SD. Responders who did not record their sex, age of onset, and current age were excluded.
P < 0.001 vs overall with childhood onset, Student's t test.
P < 0.005 vs males with childhood onset, Student's t test.
P < 0.001 vs females with childhood onset, Student's t test.